rofecoxib has been researched along with Cardiotoxicity in 2 studies
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiac adverse effects are among the leading causes of the discontinuation of clinical trials and the withdrawal of drugs from the market." | 5.56 | Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion. ( Baczkó, I; Baranyai, T; Brenner, GB; Ferdinandy, P; Gergely, TG; Giricz, Z; Görbe, A; Husti, Z; Kiss, B; Lázár, B; Makkos, A; Nagy, CT; Onódi, Z; Sághy, É; Sayour, NV; Schulz, R; Tóthfalusi, L; Varga, RS; Varró, A; Zádori, ZS, 2020) |
| "Cardiac adverse effects are among the leading causes of the discontinuation of clinical trials and the withdrawal of drugs from the market." | 1.56 | Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion. ( Baczkó, I; Baranyai, T; Brenner, GB; Ferdinandy, P; Gergely, TG; Giricz, Z; Görbe, A; Husti, Z; Kiss, B; Lázár, B; Makkos, A; Nagy, CT; Onódi, Z; Sághy, É; Sayour, NV; Schulz, R; Tóthfalusi, L; Varga, RS; Varró, A; Zádori, ZS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, N | 1 |
| Brenner, GB | 1 |
| Makkos, A | 1 |
| Nagy, CT | 1 |
| Onódi, Z | 1 |
| Sayour, NV | 1 |
| Gergely, TG | 1 |
| Kiss, B | 1 |
| Görbe, A | 1 |
| Sághy, É | 1 |
| Zádori, ZS | 1 |
| Lázár, B | 1 |
| Baranyai, T | 1 |
| Varga, RS | 1 |
| Husti, Z | 1 |
| Varró, A | 1 |
| Tóthfalusi, L | 1 |
| Schulz, R | 1 |
| Baczkó, I | 1 |
| Giricz, Z | 1 |
| Ferdinandy, P | 1 |
1 review available for rofecoxib and Cardiotoxicity
| Article | Year |
|---|---|
Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiotoxicity; Cardiovascular Diseases; Cyclooxygenase 2 I | 2020 |
1 other study available for rofecoxib and Cardiotoxicity
| Article | Year |
|---|---|
Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cardiotoxicity; Cell Survival; | 2020 |